FDA Watch: CDRH Budget May Not See Steep Cuts in FY 2026
A leaked budget document for the next fiscal year suggested non-user fee funding may be up slightly compared to recent years.
A leaked budget document for the next fiscal year suggested non-user fee funding may be up slightly compared to recent years.
From - Laboratory Industry Report
Laboratory diagnosis of Lyme disease is based on detecting the presence of antibodies against…
From - Laboratory Industry Report
A study reveals that for today's hourly workforce, missing a single shift comes at a steep cost…
From - Laboratory Industry Report
Several companies market an array of preventive tests directly to consumers. Are these companies and tests legit? What does…
From - Laboratory Industry Report
Over the past several years, the FDA has issued Emergency Use Authorization (EUA) for over a dozen different tests for…
By Leora Borgenicht bio
Before the healthcare industry can ambitiously transform to offer more accurate and personalized patient care, certain stepping stones must…
From - Laboratory Industry Report
The FDA broke new ground by clearing a pair of STD screening assays for detecting chlamydia and gonorrhea for use with extragenital specimens, specifically from the…
From - Laboratory Industry Report
Although there's no single formula for marketing a lab, there are five basic elements a marketing plan should include&…
From - Laboratory Industry Report
After a couple of years of dormancy, the FDA laboratory developed test (LDT) enforcement volcano stirred on…